[HTML] frontiersin.org

[HTML][HTML] Cancer immunotherapies: from efficacy to resistance mechanisms–not only checkpoint matters

S Wang, K Xie, T Liu - Frontiers in immunology, 2021 - frontiersin.org
The immunotherapeutic treatment of various cancers with an increasing number of immune
checkpoint inhibitors (ICIs) has profoundly improved the clinical management of advanced …
被引用次数：69 相关文章

Cancer Immunotherapies: From Efficacy to Resistance Mechanisms–Not Only Checkpoint Matters

S Wang, K Xie, T Liu - Cancer Immunotherapies: From Efficacy to …, 2022 - books.google.com
The immunotherapeutic treatment of various cancers with an increasing number of immune
checkpoint inhibitors (ICIs) has profoundly improved the clinical management of advanced …

Cancer Immunotherapies: From Efficacy to Resistance Mechanisms-Not Only Checkpoint Matters

S Wang, K Xie, T Liu - Frontiers in immunology, 2021 - pubmed.ncbi.nlm.nih.gov
The immunotherapeutic treatment of various cancers with an increasing number of immune
checkpoint inhibitors (ICIs) has profoundly improved the clinical management of advanced …
[HTML] nih.gov

[HTML][HTML] Cancer Immunotherapies: From Efficacy to Resistance Mechanisms–Not Only Checkpoint Matters

S Wang, K Xie, T Liu - Frontiers in Immunology, 2021 - ncbi.nlm.nih.gov
The immunotherapeutic treatment of various cancers with an increasing number of immune
checkpoint inhibitors (ICIs) has profoundly improved the clinical management of advanced …

Cancer Immunotherapies: From Efficacy to Resistance Mechanisms-Not Only Checkpoint Matters.

S Wang, K Xie, T Liu - Frontiers in Immunology, 2021 - europepmc.org
The immunotherapeutic treatment of various cancers with an increasing number of immune
checkpoint inhibitors (ICIs) has profoundly improved the clinical management of advanced …